Skip to main content

Walk through one insurer enquiry together.

We examine the path from the enquiry through documents, ownership and deadlines to a reviewed response. In 30 minutes, we clarify a suitable scope and possible evaluation. Please describe the workflow without patient data.
Sven Jungmann and Nikita Tarasov, co-founders of aiomics, side by side
Dr Sven Jungmann (left), physician and CEO, and Dr Nikita Tarasov, physicist and CTO, cofounders of aiomics.

Book a conversation

Choose a free slot in the calendar. The first conversation takes 30 minutes.

What is it about?

Or write to us

This helps us understand the context of your enquiry.

We reply to written enquiries within 24 hours. No automated follow-up emails; we use your details only to handle your enquiry.

Where we operate

Registered office and operations
aiomics GmbH, Rosenthaler Straße 72A, 10119 Berlin. Development and operations in Germany. Data processing and storage exclusively within the European Union.
Customer hospitals
Rehabilitation and acute-care hospitals in Germany. Advice and correspondence in German and English.
Trade mark protection in the European Union

The word mark “aiomics” is registered as a European Union trade mark with the European Union Intellectual Property Office (EUIPO) under number 019123094. It was filed on 20 December 2024 and registered on 19 April 2025, in Nice classes 9, 10, 35 and 42. A European Union trade mark has uniform effect in all 27 member states of the European Union:

Entry in the EUIPO register